other material
confidence high
sentiment positive
materiality 0.85
Silo Pharma authorizes $1M buyback; pays IR consultant 848k shares
Silo Pharma, Inc.
- Board approved stock repurchase program up to $1 million of common stock.
- Shares outstanding: 13,318,273 as of Sept 30, 2025.
- Issued 848,320 shares to IR consultant as $250k commitment fee at $0.2947/share.
- No proceeds received; shares issued under Section 4(a)(2) exemption.
- Buyback discretionary; may be suspended or discontinued anytime.